Growth factors in the pathogenesis of diabetic foot ulcers

Front Biosci (Landmark Ed). 2018 Jan 1;23(2):310-317. doi: 10.2741/4593.

Abstract

Foot ulcers affect 15% of patients with diabetes, resulting in a great health burden. The occurrence and development of diabetic foot ulcers is associated with neuropathy, peripheral arterial disease, and infection. Several growth factors are involved in these processes, including epidermal growth factor, vascular endothelial growth factor, transforming growth factor-beta, fibroblast growth factor, and erythropoietin, which could promote wound healing of patients with diabetes. Thus, this review discusses the role of these growth factors in the pathogenesis of diabetic foot ulcers, aiming to achieve novel insights into the management of diabetic foot ulcers.

Publication types

  • Review

MeSH terms

  • Diabetic Foot / complications
  • Diabetic Foot / drug therapy*
  • Diabetic Foot / physiopathology
  • Diabetic Nephropathies / complications
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / physiopathology
  • Epidermal Growth Factor / therapeutic use
  • Erythropoietin / therapeutic use
  • Humans
  • Intercellular Signaling Peptides and Proteins / therapeutic use*
  • Transforming Growth Factor beta / therapeutic use
  • Vascular Endothelial Growth Factor A / therapeutic use
  • Wound Healing / drug effects*

Substances

  • Intercellular Signaling Peptides and Proteins
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factor A
  • Erythropoietin
  • Epidermal Growth Factor